Bladder Cancer Clinical Trials

• Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003725 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer; recurrent bladder cancer
  
• High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003623 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer; prevention of bladder cancer
  
• Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00052637 - Active, not recruiting
  Bladder Cancer; recurrent bladder cancer; stage 0 bladder cancer
  
• Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00095589 - Recruiting
  Bladder Cancer; stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder
  
• Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00042887 - Active, not recruiting
  stage 0 bladder cancer; stage I bladder cancer; recurrent bladder cancer; transitional cell carcinoma of the bladder
  
• Combination Chemotherapy in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00005047 - Active, not recruiting
  stage I bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder
  
• Surgery and BCG in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00002990 - Active, not recruiting
  stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder
  
• Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00089128 - Active, not recruiting
  transitional cell carcinoma of the bladder; recurrent bladder cancer; stage III bladder cancer; stage IV bladder cancer
  
• Biological Therapy in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003779 - Active, not recruiting
  stage I bladder cancer; stage 0 bladder cancer
  
• Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
  ClinicalTrials.gov Identifier: NCT00234039 - Recruiting
  Recurrent Bladder Cancer; Stage 0 Bladder Cancer; Stage I Bladder Cancer; Transitional Cell Carcinoma of the Bladder
  
• Combination Chemotherapy in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003701 - Active, not recruiting
  stage III bladder cancer; childhood kidney/urinary cancer; transitional cell carcinoma of the bladder; ...
  
• BCG With or Without Mitomycin in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00023842 - Active, not recruiting
  stage 0 bladder cancer; recurrent bladder cancer; transitional cell carcinoma of the bladder
  
• Chemotherapy in Treating Patients With Early-Stage Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003129 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer
  
• Combination Chemotherapy in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00014534 - Active, not recruiting
  stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
  
• Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003824 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage 0 bladder cancer; recurrent bladder cancer
  
• Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00088946 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage 0 bladder cancer; stage I bladder cancer
  
• Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00006118 - Active, not recruiting
  stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
  
• Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00006105 - Active, not recruiting
  stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; Drug Toxicity
  
• Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003640 - Active, not recruiting
  stage III bladder cancer; stage II bladder cancer; childhood kidney/urinary cancer; transitional cell carcinoma of the bladder
  
• Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ
  ClinicalTrials.gov Identifier: NCT00462488 - Recruiting
  Urinary Bladder Cancer; Bladder Cancer; Bladder Neoplasms; Bladder Tumors
  
• Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00003376 - Active, not recruiting
  stage III bladder cancer; stage IV bladder cancer; urethral cancer associated with invasive bladder cancer; ...
  
• Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003642 - Active, not recruiting
  stage III bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder
  
• Cost-Effectiveness in Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00126958 - Active, not recruiting
  Bladder Cancer
  
• Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00002914 - Active, not recruiting
  recurrent urethral cancer; transitional cell carcinoma of the bladder; recurrent bladder cancer; ...
  
• Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00033436 - Active, not recruiting
  stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; transitional cell carcinoma of the bladder
  
• Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00054626 - Recruiting
  stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
  
• SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00006351 - Active, not recruiting
  recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; recurrent urethral cancer; anterior urethral cancer; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003342 - Active, not recruiting
  stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...
  
• ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00014144 - Active, not recruiting
  recurrent urethral cancer; transitional cell carcinoma of the bladder; recurrent bladder cancer; stage IV bladder cancer; ...
  
• Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003133 - Active, not recruiting
  stage III bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ...
  
• Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00005086 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage IV bladder cancer
  
• Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00002919 - Active, not recruiting
  stage II bladder cancer; transitional cell carcinoma of the bladder
  
• Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00002490 - Active, not recruiting
  stage I bladder cancer; transitional cell carcinoma of the bladder
  
• Arsenic Trioxide in Treating Patients With Recurrent Bladder or Urinary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00009867 - Active, not recruiting
  recurrent urethral cancer; transitional cell carcinoma of the bladder; recurrent bladder cancer; ...
  
• Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00004203 - Active, not recruiting
  transitional cell carcinoma of the bladder; recurrent bladder cancer; stage IV bladder cancer; ...
  
• Celecoxib in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00006124 - Active, not recruiting
  recurrent bladder cancer
  
• Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00004223 - Active, not recruiting
  stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; transitional cell carcinoma of the bladder; ...
  
• Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00022191 - Active, not recruiting
  stage IV bladder cancer; transitional cell carcinoma of the bladder; urethral cancer associated with invasive bladder cancer; ...
  
• Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the Bladder
  ClinicalTrials.gov Identifier: NCT00070070 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage I bladder cancer
  
• R115777 in Treating Patients With Advanced Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00006376 - Active, not recruiting
  stage III bladder cancer; stage II bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; ...
  
• Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00006111 - Active, not recruiting
  stage III bladder cancer; stage II bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; anterior urethral cancer; ...
  
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
  ClinicalTrials.gov Identifier: NCT00005958 - Active, not recruiting
  stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; transitional cell carcinoma of the bladder; ...
  
• Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients with Advanced Transitional Cell Cancer of the Bladder
  ClinicalTrials.gov Identifier: NCT00136175 - Active, not recruiting
  Bladder Cancer
  
• Antineoplaston Therapy in Treating Patients With Stage IV Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003452 - Recruiting
  Recurrent Bladder Cancer; Stage IV Bladder Cancer
  
• Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003930 - Active, not recruiting
  stage III bladder cancer; stage II bladder cancer
  
• Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
  ClinicalTrials.gov Identifier: NCT00233402 - Active, not recruiting
  Bladder Cancer
  
• Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00002684 - Active, not recruiting
  Bladder Cancer; Urethral Cancer
  
• Detection of Bladder Cancer Microsatellite Analysis (MSA) of Urinary Sediment
  ClinicalTrials.gov Identifier: NCT00185627 - Active, not recruiting
  Bladder Cancer
  
• Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00186277 - Active, not recruiting
  Bladder Cancer
  
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00024349 - Recruiting
  stage II bladder cancer; stage III bladder cancer; transitional cell carcinoma of the bladder; squamous cell carcinoma of the bladder; ...
  
• Interdisciplinary Case-Control Study of Bladder Cancer in Spain
  ClinicalTrials.gov Identifier: NCT00341861 - Active, not recruiting
  Bladder Cancer
  
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
  ClinicalTrials.gov Identifier: NCT00389155 - Active, not recruiting
  Bladder Cancer; Transitional Cell Carcinoma; Metastasis
  
• Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
  ClinicalTrials.gov Identifier: NCT00028756 - Recruiting
  stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
  
• Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00041106 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003105 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter
  
• Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
  ClinicalTrials.gov Identifier: NCT00002949 - Active, not recruiting
  stage III bladder cancer; stage III endometrial cancer; stage II bladder cancer; stage II cervical cancer; stage III cervical cancer; ...
  
• Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00006026 - Active, not recruiting
  Bladder Cancer; Kidney Cancer; Urethral Cancer
  
• Gemcitabine, Paclitaxel, Doxorubicin, and Pegfilgrastim in Treating Patients With Metastatic or Unresectable Bladder Cancer or Urinary Tract Cancer and Kidney Dysfunction
  ClinicalTrials.gov Identifier: NCT00478361 - Recruiting
  Bladder Cancer; Neutropenia; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
  ClinicalTrials.gov Identifier: NCT00005644 - Active, not recruiting
  Bladder Cancer; Cancer of the Renal Pelvis and Ureter; Gastrointestinal Cancer; Urethral Cancer
  
• Instillation of Gemcitabine in Patients With Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00191477 - Active, not recruiting
  Bladder Neoplasms
  
• A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-Invasive Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00412971 - Active, not recruiting
  Bladder Cancer
  
• Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00322699 - Recruiting
  Superficial Bladder Cancer
  
• Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00393809 - Active, not recruiting
  Bladder Neoplasms
  
• Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00553345 - Recruiting
  Bladder Cancer
  
• Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
  ClinicalTrials.gov Identifier: NCT00084578 - Completed
  stage 0 bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; ...
  
• Combination Chemotherapy and Radiation Therapy With or Without Surgery In Treating Patients With Stage II or Stage III Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00055601 - Recruiting
  stage II bladder cancer; stage III bladder cancer
  
• Phase II Trial of EOquin in High-Risk Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00141531 - Active, not recruiting
  Bladder Neoplasms
  
• A Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Patients With Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00318643 - Recruiting
  Bladder Cancer
  
• Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin
  ClinicalTrials.gov Identifier: NCT00516750 - Recruiting
  Bladder Cancer
  
• Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00238420 - Recruiting
  Bladder Cancer
  
• Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00553566 - Recruiting
  Bladder Cancer
  
• Phase I & II Trial of Intravesicular Abraxane for Treatment-Refractory Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00583349 - Recruiting
  Bladder Cancer
  
• The New England Bladder Cancer Study
  ClinicalTrials.gov Identifier: NCT00342875 - Active, not recruiting
  Bladder Cancer
  
• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004095 - Active, not recruiting
  Bladder Cancer; Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer
  
• FR901228 in Treating Patients With Advanced Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00087295 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00445601 - Recruiting
  Bladder Cancer
  
• Survivin Urine mRNA Assay Risk of Bladder Cancer Study
  ClinicalTrials.gov Identifier: NCT00315653 - Recruiting
  Bladder Cancer
  
• BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00352079 - Recruiting
  Bladder Cancer
  
• Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00380029 - Recruiting
  Bladder Cancer
  
• Prospective Trial to Evaluate Efficacy and Accuracy of a Portable Ultrasound Scanner for Non-Invasive Bladder Volume Measurement (BladderScan BVI3000) in Patients After Radical Cystectomy and Bladder Reconstruction
  ClinicalTrials.gov Identifier: NCT00512174 - Recruiting
  Bladder Substitution; Reconstructed Bladder
  
• Biobank Bladder Carcinoma
  ClinicalTrials.gov Identifier: NCT00157365 - Recruiting
  Bladder Cancer
  
• Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00350688 - Recruiting
  Bladder Cancer
  
• Sunitinib in Treating Patients With Locally Advanced Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00526656 - Recruiting
  Bladder Cancer
  
• Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00553124 - Recruiting
  Bladder Cancer
  
• Zinc Supplements in Lowering Cadmium Levels in Smokers
  ClinicalTrials.gov Identifier: NCT00376987 - Active, not recruiting
  Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
  
• Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant Instilled in the Early Postoperative Period in Patients Undergoing Transurethral Resection for Noninvasive Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00461591 - Recruiting
  Bladder Cancer
  
• Gene Therapy in Treating Patients With Advanced Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003167 - Completed
  stage III bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder; stage I bladder cancer; recurrent bladder cancer; ...
  
• Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00022633 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003175 - Active, not recruiting
  recurrent transitional cell cancer of the renal pelvis and ureter; recurrent urethral cancer; childhood kidney/urinary cancer; ...
  
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00053209 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium
  ClinicalTrials.gov Identifier: NCT00072150 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Fenretinide to Prevent Cancer Recurrence in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00004154 - Completed
  stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder
  
• Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00066612 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00112671 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter
  
• Tipifarnib in Treating Patients With Recurrent Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00047216 - Completed
  recurrent bladder cancer; stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder
  
• Genistein in Treating Patients Who Are Undergoing Surgery for Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00118040 - Suspended
  stage 0 bladder cancer; recurrent bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer
  
• Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00005831 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Identifying Methylation Biomarkers for Monitoring Bladder Tumors
  ClinicalTrials.gov Identifier: NCT00244205 - Recruiting
  Bladder Cancer
  
• NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers.
  ClinicalTrials.gov Identifier: NCT00318266 - Recruiting
  Bladder Cancer
  
• Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00556621 - Recruiting
  Bladder Cancer